BioCentury
ARTICLE | Clinical News

Cyclacel preclinical data

May 3, 2010 7:00 AM UTC

CYC065 induced apoptosis in CLL cell lines with about 30-fold greater potency than selicicib in vitro. CYC065 is a second-generation inhibitor of cyclin dependent kinases 2E, 2A, 7 and 9. Data were pr...